The Future of MRI Contrast
The New Standard in MRI Contrasts
Inventure’s GADZero Ultra achieves a breakthrough in MRI safety by removing weak molecular cages, resulting in an exceptionally pure formulation. Built on proven, trusted compounds, it delivers the same reliable diagnostic performance while reducing free gadolinium exposure by up to 1,400%.
ABOUT INVENTURE
Making Every Scan Safer
For decades, gadolinium-based contrast agents (GBCAs) have improved diagnostic precision—but at a biological cost. Trace gadolinium can remain in the body for months or even years after scanning.
Inventure solves this problem through chemistry. Our Dynamic Equilibrium Stabilization process removes weak molecular cages, creating GADZero Ultra, the first ultra-stable contrast class built on proven molecules already trusted in medical practice.
Learn more about Dynamic Equilibrium Stabilization and Gad Zero Ultra
Smart Chemistry for Safer Imaging
A 1,400% Leap Forward in MRI Contrast Safety
Inventure’s Dynamic Equilibrium Stabilization (DES) process enhances the molecular integrity of existing MRI contrast agents, such as Gadoterate Meglumine and Gadobutrol. By removing weak molecular cages, we minimize free gadolinium release—enabling safer imaging without changing dosage, workflow, or image quality.
01.
Same Dose, Safer Profile
Delivers the familiar dosing and workflow clinicians know—now with a substantially lower free gadolinium burden.
Repeat-Scan Friendly
Meaningfully lowers cumulative free Gadolinium exposure for patients needing serial contrast imaging at a ratio of 14:1.
Flexible Preparation
Available in Mix on Demand or dry configurations (dual-chamber syringe or vial) to fit existing pharmacy workflows.
Built on Trusted Macrocyclic Agents
We start with well-known formulations (e.g., Gadoterate Meglumine, Gadobutrol) and make them ultra-stable.
No Change to Imaging Workflow
Integrates seamlessly with current contrast protocols, imaging equipment, and everyday clinical practice routines.
Designed for Vulnerable Populations
Reduces free gadolinium exposure in groups most sensitive to retention—such as CKD and repeat-scan patients.
Expanding Access Through Safer Innovation
Making Contrast-Enhanced MRI Safer for All
Many people who rely on ongoing or repeat MRI scans face limits on contrast use because of long-term safety concerns.
GADZero Ultra offers a practical path forward—providing a significantly safer contrast profile that preserves imaging consistency across every scan.
By improving molecular stability within existing agents, Inventure is enabling broader access to high-quality, contrast-enhanced diagnostics worldwide.
built around patient needs
Where Safer MRI Contrast Makes the
Greatest Difference
GADZero Ultra brings breakthrough MRI safety to those who need it most. By lowering free gadolinium exposure while maintaining proven diagnostic performance, Inventure’s innovation expands the safe use of contrast-enhanced imaging across diverse patient populations and clinical disciplines.
Chronic Kidney Disease Patients
GADZero Ultra’s stability supports safe imaging for patients with reduced kidney function, helping physicians capture critical diagnostic detail with greater confidence.
Patients Requiring Multiple MRI Scans
Our advanced formulation enables repeat contrast imaging for ongoing monitoring—delivering consistent results while minimizing cumulative gadolinium exposure over time.
Cancer Screening
For annual or high-risk screenings, GADZero Ultra combines high-definition contrast with a safer profile, helping detect disease early without added risk.
